Published in AIDS Weekly and Law, September 7th, 2006
The results of the study clearly indicated that 75% of the tested mice injected with 5 mg of QR-433 were protected from cachexia and did not exhibit any significant weight loss compared to untreated control animals which exhibited a 15-25 percent weight loss at the end of the experiment.
Cachexia, an extremely debilitating and life threatening condition, is a loss of weight, muscle wasting,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly and Law
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.